The global Budesonide (BUD) market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Budesonide (BUD) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Budesonide (BUD) market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Budesonide (BUD) in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Budesonide (BUD) manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
AstraZeneca
Cosmo Pharmaceuticals
Teva
Mylan
Sandoz
Dr. Falk Pharma
Chiesi Farmaceutici S.p.A
Orion Corporation
Cipla
Synmosa Biopharma Corporation
Lunan Better Pharmaceutical
Shanghai Sine Promod Pharmaceutical

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Nasal Spray
Inhaler
Pill&Rectal Forms

Segment by Application
Respiratory Disease Treatment
Nose Disease Treatment
Inflammatory Bowel Disease Treatment